Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum is a research paper published in The Journal of Infectious Diseases (2020). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: U01 HL123336
National Heart, Lung, and Blood Institute
Grant: U01 HL123339
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI068636
National Institute of Allergy and Infectious Diseases
Grant: UM1 AI106701
NIAID NIH HHS
Grant: U01 AI069463
NIAID NIH HHS
Grant: UM1 AI069456
NCATS NIH HHS
Grant: UL1 TR002384
NIAID NIH HHS
Grant: UM1 AI069463
NIDDK NIH HHS
Grant: P30 DK040561
NIAID NIH HHS
Grant: UM1 AI068634
National Institutes of Health
Grant: 5U01HL123336-02
REPRIEVE - CCC - Lead Application
National Institutes of Health
Grant: 3UM1AI068636-19SC
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
National Institutes of Health
Grant: 5U01HL123339-02
REPRIEVE - DCC
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
FWCI
1.04
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals